{"originalText": "，患者自述于3年3个月因无意扪及左乳一肿物，于我院行乳腺超声及钼靶怀疑恶性可能性大，后于我院乳腺外科行乳腺根治性切除术(2008.2.23)。术中见肿物5.5×4.0×3.5厘米，，术后病理为：浸润性导管癌，淋巴结6/12枚转移（病理号381609），免疫组化：ER(+++)，PR(+++),，HER-2:阴性。术后在乳腺外科行CE方案化疗4周期，，具体方案为：环磷酰胺1.0毫克，表阿霉素130毫克。期间行放疗1周期。后序贯紫杉醇4周期(具体计量不详）.化疗时出现脱发，轻度恶心。化疗结束后口服他莫西芬。1年余前常规体检中发现肝有一病灶，约1.0CM，未行系统治疗。11个月前行卵巢去势术，9个月前开始口服瑞宁德。8个月前复查，病情进展，遂入我科行GX方案化疗8周期，，具体方案为：吉西他滨（健泽）1.6D1，1.2D8,卡培他滨（希罗达）1.5日二次口服D1-14，因骨髓抑制较重，第2周期*吉西他滨改量为1.4D1,D8，并用唑来膦酸钠（盖宁）抗骨转移治疗，期间评效，病情稳定，末次化疗距今3周，未出现II度以下不良反应，为继续治疗入我科。近1个月来饮食睡眠正常，二便基本正常，体重正常。KPS评分90分。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "影像检查", "overlap": 0, "start_pos": 26, "end_pos": 30}, {"label_type": "影像检查", "overlap": 0, "start_pos": 31, "end_pos": 33}, {"end_pos": 59, "label_type": "手术", "overlap": 0, "start_pos": 51}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 97, "end_pos": 103}, {"end_pos": 186, "label_type": "药物", "overlap": 0, "start_pos": 182}, {"end_pos": 196, "label_type": "药物", "overlap": 0, "start_pos": 192}, {"end_pos": 217, "label_type": "药物", "overlap": 0, "start_pos": 214}, {"end_pos": 253, "label_type": "药物", "overlap": 0, "start_pos": 249}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 296, "label_type": "手术", "overlap": 0, "start_pos": 291}, {"end_pos": 308, "label_type": "药物", "overlap": 0, "start_pos": 305}, {"end_pos": 347, "label_type": "药物", "overlap": 0, "start_pos": 343}, {"end_pos": 350, "label_type": "药物", "overlap": 0, "start_pos": 348}, {"end_pos": 367, "label_type": "药物", "overlap": 0, "start_pos": 363}, {"end_pos": 371, "label_type": "药物", "overlap": 0, "start_pos": 368}, {"end_pos": 403, "label_type": "药物", "overlap": 0, "start_pos": 399}, {"end_pos": 422, "label_type": "药物", "overlap": 0, "start_pos": 417}, {"end_pos": 425, "label_type": "药物", "overlap": 0, "start_pos": 423}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 427}]}
